Strawberry Chews

Name: Strawberry Chews
SKU: 146673
Availability: InStock

$26.00

Hybrid

THC 100mg

Sweet strawberry flavor paired with GG4’s chocolate, coffee, and diesel notes
Infused with 10mg THC per chew, 100mg THC per package
Features the hybrid strain GG4 for a full-bodied flavor experience
Ideal for a balanced and flavorful edible option

$26 / 1.62oz

9 in stock

Description

Strawberry Chews offer a delightful combination of juicy strawberry notes paired with savory GG4 strain flavors. These chews are infused with GG4, a hybrid strain known for its full-bodied and flavorful notes of chocolate, coffee, and diesel. Each piece contains 10mg of THC, and the entire package offers 100mg. Indulge in the bright strawberry taste that perfectly complements the unique characteristics of GG4.

Brand

Kiva Confections

Kiva Confections, founded in 2010 by Scott and Kristi Palmer, set out to elevate the cannabis edibles market with premium products crafted from sustainably-sourced ingredients. Known for their artisanal edibles like Kiva Bars, Terra Bites, Petra Mints, Camino Gummies, and Lost Farm Chews, Kiva emphasizes precise dosing, consistency, and natural flavors to provide a reliable and enjoyable cannabis experience. As the top-selling edibles brand in the U.S., Kiva is committed to sustainability, with eco-friendly packaging, and social responsibility, notably through initiatives like the Kiva Cares Project, which donates safe cannabis products to medical patients in need.

Lost Farm

Lost Farm by Kiva Confections offers strain-specific, plant-based gummies and chews infused with 100% live resin and solventless live rosin for a full-spectrum, true-to-the-plant cannabis experience. With 10mg of THC per serving, these edibles are designed for seasoned consumers seeking a distinct and potent high. Inspired by the mythical pursuit of unattainable treasures, Lost Farm embodies the spirit of exploration in cannabis consumption, delivering products that capture the essence of the plant's original flavor and effects through innovative infusion techniques.